R. Fontaine, M. Kim, R. Kieny, R. Rutherford, J. Baker et al., Recommended standards for reports dealing with lower extremity ischemia: revised version Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus al. Peripheral Arterial Disease as an Independent Predictor for Excess Stroke Morbidity and Mortality in Primary-Care Patients: 5-Year Results of the getABI Study, Helv Chir Acta J Vasc Surg J Vasc Surg Int J Epidemiol Ann Intern Med Cerebrovasc Dis, vol.2126452014129, pp.499-533517, 1954.

D. Bhatt, P. Steg, E. Ohman, A. Hirsch, Y. Ikeda et al., International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC), JAMA J Vasc Surg, vol.29531, pp.180-189, 2000.

M. Jaff, C. White, W. Hiatt, G. Fowkes, J. Dormandy et al., An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), Annals of Vascular Diseases, vol.8, issue.4, pp.343-57, 2015.
DOI : 10.3400/avd.tasc.15-01000

J. Kunlin, Long vein transplantation in treatment of ischemia caused by arteritis], Rev Chir, vol.70, pp.206-241, 1951.

C. Campbell, D. Brooks, M. Webster, and H. Bahnson, The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report, Surgery, vol.79, pp.485-91, 1976.

C. Twine and A. Mclain, Graft type for femoro-popliteal bypass surgery, Cochrane Database Syst. Rev, vol.15, issue.2:
DOI : 10.1111/j.1524-475X.2007.00294.x

D. Midy, X. Papon, P. Patra, H. Kodja, R. Feugier et al., Randomized Study of Noninferiority Comparing Prosthetic and Autologous Vein Above-Knee Femoropopliteal Bypasses, Annals of Vascular Surgery, vol.31, pp.99-104, 2016.
DOI : 10.1016/j.avsg.2015.07.047

I. Rychlik, P. Davey, J. Murphy, O. Donnell, and M. , A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass, Journal of Vascular Surgery, vol.60, issue.2, pp.506-521, 2014.
DOI : 10.1016/j.jvs.2014.05.049

A. Aburahma, P. Robinson, and S. Holt, Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses, Surgery, vol.126, issue.4, pp.594-602, 1999.
DOI : 10.1016/S0039-6060(99)70110-8

F. Veith, S. Gupta, E. Ascer, S. White-flores, R. Samson et al., Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions, Journal of Vascular Surgery, vol.3, issue.1, pp.104-114, 1986.
DOI : 10.1016/0741-5214(86)90073-X

R. Green, W. Abbott, T. Matsumoto, J. Wheeler, N. Miller et al., Prosthetic above-knee femoropopliteal bypass grafting: Five-year results of a randomized trial, Journal of Vascular Surgery, vol.31, issue.3, pp.417-442, 2000.
DOI : 10.1067/mva.2000.103238

W. Johnson and K. Lee, A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: A prospective randomized Department of Veterans Affairs cooperative study, Journal of Vascular Surgery, vol.32, issue.2, pp.268-77, 2000.
DOI : 10.1067/mva.2000.106944

C. Pereira, M. Albers, M. Romiti, F. Brochado-neto, and C. Pereira, Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency, Journal of Vascular Surgery, vol.44, issue.3, pp.510-517, 2006.
DOI : 10.1016/j.jvs.2006.04.054

D. Adam, J. Beard, C. T. Bell, J. Bradbury, A. Forbes et al., Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet Lond Engl, vol.366, issue.05, pp.1925-1959, 2005.

A. Grüntzig and H. Hopff, Perkutane Rekanalisation chronischer arterieller Verschl??sse mit einem neuen Dilatationskatheter, DMW - Deutsche Medizinische Wochenschrift, vol.99, issue.49, pp.2502-2512, 19461974.
DOI : 10.1055/s-0028-1108161

A. Klein, J. Chen, S. Messenger, J. Hansgen, A. Plomondon et al., Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement, Catheterization and Cardiovascular Interventions, vol.48, issue.Pt 1, pp.787-98, 2009.
DOI : 10.1097/01.RVI.0000151260.74519.CA

B. Mwipatayi, A. Hockings, M. Hofmann, M. Garbowski, and K. Sieunarine, Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis, Journal of Vascular Surgery, vol.47, issue.2, pp.461-470, 2008.
DOI : 10.1016/j.jvs.2007.07.059

M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi et al., Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery, New England Journal of Medicine, vol.354, issue.18, pp.1879-88, 2006.
DOI : 10.1056/NEJMoa051303

P. Dick, H. Wallner, S. Sabeti, C. Loewe, W. Mlekusch et al., Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions, Catheterization and Cardiovascular Interventions, vol.83, issue.7, pp.1090-1095, 2009.
DOI : 10.1097/01.RVI.0000151260.74519.CA

K. Johnston, Femoral and popliteal arteries: reanalysis of results of balloon angioplasty., Radiology, vol.183, issue.3, pp.767-71, 1992.
DOI : 10.1148/radiology.183.3.1294068

P. Capek, G. Mclean, and H. Berkowitz, Femoropopliteal angioplasty. Factors influencing long-term success, Circulation, vol.83, pp.70-80, 1991.

M. Cejna, S. Thurnher, H. Illiasch, W. Horvath, P. Waldenberger et al., PTA versus Palmaz Stent Placement in Femoropopliteal Artery Obstructions: A Multicenter Prospective Randomized Study, Journal of Vascular and Interventional Radiology, vol.12, issue.1, pp.23-31, 2001.
DOI : 10.1016/S1051-0443(07)61397-9

J. Grimm, S. Müller-hülsbeck, T. Jahnke, C. Hilbert, J. Brossmann et al., Randomized Study to Compare PTA Alone versus PTA with Palmaz Stent Placement for Femoropopliteal Lesions, Journal of Vascular and Interventional Radiology, vol.12, issue.8, pp.935-977, 2001.
DOI : 10.1016/S1051-0443(07)61572-3

D. Vroegindeweij, L. Vos, A. Tielbeek, J. Buth, and H. Bosch, Balloon Angioplasty Combined with Primary Stenting Versus Balloon Angioplasty Alone in Femoropopliteal Obstructions: A Comparative Randomized Study, CardioVascular and Interventional Radiology, vol.20, issue.6, pp.420-425, 1997.
DOI : 10.1007/s002709900186

E. Armstrong, H. Saeed, B. Alvandi, S. Singh, G. Singh et al., Nitinol Self-Expanding Stents vs. Balloon Angioplasty for Very Long Femoropopliteal Lesions, Journal of Endovascular Therapy, vol.21, issue.1, pp.34-43, 2014.
DOI : 10.1583/13-4399MR.1

B. Gray, T. Sullivan, M. Childs, J. Young, and J. Olin, High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty, Journal of Vascular Surgery, vol.25, issue.1, pp.74-83, 1997.
DOI : 10.1016/S0741-5214(97)70323-9

H. Krankenberg, M. Schluter, H. Steinkamp, K. Burgelin, D. Scheinert et al., Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST), Circulation, vol.116, issue.3, pp.285-92, 2007.
DOI : 10.1161/CIRCULATIONAHA.107.689141

J. Laird, B. Katzen, D. Scheinert, J. Lammer, J. Carpenter et al., Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: Twelve-Month Results From the RESILIENT Randomized Trial, Circulation: Cardiovascular Interventions, vol.3, issue.3, pp.267-76, 2010.
DOI : 10.1161/CIRCINTERVENTIONS.109.903468

J. Matsumura, D. Yamanouchi, J. Goldstein, C. Pollock, M. Bosiers et al., The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Prot??g?? EverfLex NitInol STent SYstem II (DURABILITY II), Journal of Vascular Surgery, vol.58, issue.1, pp.73-83, 2013.
DOI : 10.1016/j.jvs.2012.12.066

J. Davaine, L. Azéma, B. Guyomarch, P. Chaillou, A. Costargent et al., One-year Clinical Outcome after Primary Stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D Femoropopliteal Lesions (The STELLA ???STEnting Long de L'Art??re f??morale superficielle??? Cohort), European Journal of Vascular and Endovascular Surgery, vol.44, issue.4, pp.432-473, 2012.
DOI : 10.1016/j.ejvs.2012.07.015

M. Elmahdy, P. Buonamici, M. Trapani, R. Valenti, A. Migliorini et al., Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions, Heart, Lung and Circulation, vol.26, issue.6, pp.604-615, 2017.
DOI : 10.1016/j.hlc.2016.09.011

M. Bosiers, K. Deloose, J. Callaert, N. Moreels, K. Keirse et al., Results of the Prot??g?? EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions, Journal of Vascular Surgery, vol.54, issue.4, pp.1042-50, 2011.
DOI : 10.1016/j.jvs.2011.03.272

J. Brouillet, K. Deloose, Y. Goueffic, M. Poirier, D. Midy et al., Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients, J Cardiovasc Surg, 2016.

D. Scheinert, S. Scheinert, J. Sax, C. Piorkowski, S. Bräunlich et al., Prevalence and clinical impact of stent fractures after femoropopliteal stenting, Journal of the American College of Cardiology, vol.45, issue.2, pp.312-317, 2005.
DOI : 10.1016/j.jacc.2004.11.026

L. Garcia, M. Jaff, C. Metzger, G. Sedillo, A. Pershad et al., Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial, Circulation: Cardiovascular Interventions, vol.8, issue.5, 2015.
DOI : 10.1161/CIRCINTERVENTIONS.113.000937

O. Iida, M. Uematsu, Y. Soga, K. Hirano, K. Suzuki et al., Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses, Catheterization and Cardiovascular Interventions, vol.20, issue.4, pp.611-618, 2011.
DOI : 10.1097/00005344-199212000-00009

S. Scali, E. Rzucidlo, A. Bjerke, D. Stone, D. Walsh et al., Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease, Journal of Vascular Surgery, vol.54, issue.3, pp.714-735, 2011.
DOI : 10.1016/j.jvs.2011.03.216

P. Geraghty, M. Mewissen, M. Jaff, and G. Ansel, Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease, Journal of Vascular Surgery, vol.58, issue.2, 2013.
DOI : 10.1016/j.jvs.2013.01.050

M. Liu, G. Roubin, and S. King, Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia, Circulation, vol.79, issue.6, pp.1374-87, 1989.
DOI : 10.1161/01.CIR.79.6.1374

S. Morimoto, Y. Mizuno, S. Hiramitsu, K. Yamada, N. Kubo et al., Restenosis after percutaneous transluminal coronary angioplasty. A histopathological study using autopsied hearts., Japanese Circulation Journal, vol.54, issue.1, pp.43-56, 1990.
DOI : 10.1253/jcj.54.43

E. Ducasse, J. Cosset, F. Eschwège, C. J. De-ravignan, D. Puppinck et al., Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives], J Mal Vasc, vol.28, pp.130-174, 2003.

G. Bauriedel, R. Kandolf, S. Schluckebier, and U. Welsch, Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses, The American Journal of Cardiology, vol.77, issue.7, pp.468-74, 1996.
DOI : 10.1016/S0002-9149(97)89339-3

I. Schorn, H. Malinoff, S. Anderson, C. Lecy, J. Wang et al., The L utonix ?? drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease, Advanced Drug Delivery Reviews, vol.112, pp.78-87, 2017.
DOI : 10.1016/j.addr.2017.05.015

I. Sarembock, P. Laveau, S. Sigal, I. Timms, J. Sussman et al., Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit, Circulation, vol.80, issue.4, pp.1029-1040, 1989.
DOI : 10.1161/01.CIR.80.4.1029

C. Roiron, Drug eluting stents: an updated meta-analysis of randomised controlled trials, Heart, vol.92, issue.5, pp.641-650, 2006.
DOI : 10.1136/hrt.2005.061622

S. Duda, Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Six-Month Results, Circulation, vol.106, issue.12, pp.1505-1514, 2002.
DOI : 10.1161/01.CIR.0000029746.10018.36

S. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller et al., Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial, J Endovasc Ther Off J Int Soc Endovasc Spec, vol.13, pp.701-711, 2006.

J. Lammer, M. Bosiers, T. Zeller, M. Schillinger, E. Boone et al., First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease, Journal of Vascular Surgery, vol.54, issue.2, pp.394-401, 2011.
DOI : 10.1016/j.jvs.2011.01.047

M. Dake, G. Ansel, M. Jaff, T. Ohki, R. Saxon et al., Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results, Circulation: Cardiovascular Interventions, vol.4, issue.5, pp.495-504, 2011.
DOI : 10.1161/CIRCINTERVENTIONS.111.962324

M. Dake, G. Ansel, M. Jaff, T. Ohki, R. Saxon et al., Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions, Journal of the American College of Cardiology, vol.61, issue.24, pp.2417-2444, 2013.
DOI : 10.1016/j.jacc.2013.03.034

M. Dake, G. Ansel, M. Jaff, T. Ohki, R. Saxon et al., Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal ArteryCLINICAL PERSPECTIVE, Circulation, vol.133, issue.15, pp.1472-1483, 2016.
DOI : 10.1161/CIRCULATIONAHA.115.016900

M. Dake, D. Scheinert, G. Tepe, J. Tessarek, F. Fanelli et al., Nitinol stents with polymerfree paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study, J Endovasc Ther Off J Int Soc Endovasc Spec, vol.18, pp.613-636, 2011.

K. Deloose, Surgical Bypass vs. Zilver PTX stent for long SFA lesions : Interim results of the ZilverPass Trial, 2017.

W. Van-der-giessen, A. Lincoff, R. Schwartz, H. Van-beusekom, P. Serruys et al., Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries, Circulation, vol.94, issue.7, pp.1690-1697, 1996.
DOI : 10.1161/01.CIR.94.7.1690

B. Scheller, Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis, Circulation, vol.110, issue.7, pp.810-814, 2004.
DOI : 10.1161/01.CIR.0000138929.71660.E0

A. Pósa, N. Nyolczas, R. Hemetsberger, N. Pavo, Ö. Petnehazy et al., Optimization of drug-eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries, Catheterization and Cardiovascular Interventions, vol.64, issue.3, pp.395-403, 2010.
DOI : 10.1002/ccd.22468

T. Luscher, J. Steffel, F. Eberli, M. Joner, G. Nakazawa et al., Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications, Circulation, vol.115, issue.8, pp.1051-1059, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.675934

M. Costa, Molecular Basis of Restenosis and Drug-Eluting Stents, Circulation, vol.111, issue.17, pp.2257-73, 2005.
DOI : 10.1161/01.CIR.0000163587.36485.A7

B. Scheller, U. Speck, A. Schmitt, M. Böhm, and G. Nickenig, Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation, Journal of the American College of Cardiology, vol.42, issue.8, pp.1415-1435, 2003.
DOI : 10.1016/S0735-1097(03)01056-8

G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwälder et al., Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg, New England Journal of Medicine, vol.358, issue.7, pp.689-699, 2008.
DOI : 10.1056/NEJMoa0706356

R. Houbballah, J. Marzelle, F. Cochennec, F. Bellenot, and J. Becquemin, Techniques endovasculaires de base en chirurgie vasculaire, 2014.

D. Axel, W. Kunert, C. Göggelmann, M. Oberhoff, C. Herdeg et al., Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery, Circulation, vol.96, issue.2, pp.636-681, 1997.
DOI : 10.1161/01.CIR.96.2.636

W. Kempin, S. Kaule, T. Reske, N. Grabow, S. Petersen et al., In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons, European Journal of Pharmaceutics and Biopharmaceutics, vol.96, 2015.
DOI : 10.1016/j.ejpb.2015.08.010

J. Granada, M. Stenoien, P. Buszman, A. Tellez, D. Langanki et al., Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing, Open Heart, vol.66, issue.1, p.117, 2014.
DOI : 10.1158/0008-5472.CAN-05-3885

C. Gongora, M. Shibuya, J. Wessler, J. Mcgregor, A. Tellez et al., Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing, JACC: Cardiovascular Interventions, vol.8, issue.8, pp.1115-1138, 2015.
DOI : 10.1016/j.jcin.2015.03.020

S. Kaule, I. Minrath, F. Stein, U. Kragl, W. Schmidt et al., Correlating Coating Characteristics with the Performance of Drug-Coated Balloons ??? A Comparative In Vitro Investigation of Own Established Hydrogel- and Ionic Liquid-Based Coating Matrices, PLOS ONE, vol.50, issue.5, 2015.
DOI : 10.1371/journal.pone.0116080.s001

B. Cremers, M. Biedermann, D. Mahnkopf, M. Böhm, and B. Scheller, Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model, Clinical Research in Cardiology, vol.358, issue.5, pp.325-355, 2009.
DOI : 10.1161/01.CIR.103.18.2289

U. Speck, B. Cremers, B. Kelsch, M. Biedermann, Y. Clever et al., Do Pharmacokinetics Explain Persistent Restenosis Inhibition by a Single Dose of Paclitaxel?, Circulation: Cardiovascular Interventions, vol.5, issue.3, pp.392-400, 2012.
DOI : 10.1161/CIRCINTERVENTIONS.111.967794

B. Kelsch, B. Scheller, M. Biedermann, Y. Clever, S. Schaffner et al., Dose Response to Paclitaxel-Coated Balloon Catheters in the Porcine Coronary Overstretch and Stent Implantation Model, Investigative Radiology, vol.46, issue.4, pp.255-63, 2011.
DOI : 10.1097/RLI.0b013e31820577df

P. Freyhardt, T. Zeller, T. Kröncke, U. Schwarzwaelder, N. Schreiter et al., Plasma Levels Following Application of Paclitaxel-Coated Balloon Catheters in Patients with Stenotic or??Occluded Femoropopliteal Arteries, R??Fo - Fortschritte auf dem Gebiet der R??ntgenstrahlen und der bildgebenden Verfahren, vol.183, issue.05, pp.448-55, 2011.
DOI : 10.1055/s-0029-1246028

V. Virga, E. Stabile, G. Biamino, L. Salemme, A. Cioppa et al., Drug-Eluting Balloons for the Treatment of??the Superficial Femoral Artery In-Stent Restenosis, JACC: Cardiovascular Interventions, vol.7, issue.4, 2014.
DOI : 10.1016/j.jcin.2013.11.020

H. Krankenberg, T. Tübler, M. Ingwersen, M. Schlüter, D. Scheinert et al., Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent RestenosisCLINICAL PERSPECTIVE, Circulation, vol.132, issue.23, pp.2230-2236, 2015.
DOI : 10.1161/CIRCULATIONAHA.115.017364

A. Tosaka, Y. Soga, O. Iida, T. Ishihara, K. Hirano et al., Classification and Clinical Impact of Restenosis After Femoropopliteal Stenting, Journal of the American College of Cardiology, vol.59, issue.1, pp.16-23, 2012.
DOI : 10.1016/j.jacc.2011.09.036

P. Dick, S. Sabeti, W. Mlekusch, O. Schlager, J. Amighi et al., Conventional Balloon Angioplasty versus Peripheral Cutting Balloon Angioplasty for Treatment of Femoropopliteal Artery In-Stent Restenosis: Initial Experience, Radiology, vol.248, issue.1, pp.297-302, 2008.
DOI : 10.1148/radiol.2481071159

N. Shammas, G. Shammas, T. Helou, C. Voelliger, L. Mrad et al., Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center, Cardiovascular Revascularization Medicine, vol.13, issue.4, pp.224-231, 2012.
DOI : 10.1016/j.carrev.2012.03.004

N. Shammas, G. Shammas, A. Hafez, R. Kelly, E. Reynolds et al., Safety and One-Year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center, Cardiovascular Revascularization Medicine, vol.13, issue.6, pp.341-345, 2012.
DOI : 10.1016/j.carrev.2012.08.012

J. Trentmann, N. Charalambous, M. Djawanscher, J. Schäfer, and T. Jahnke, Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery, J Cardiovasc Surg (Torino), vol.51, pp.551-60, 2010.

T. Zeller, A. Rastan, S. Sixt, U. Schwarzwälder, T. Schwarz et al., Long-term results after directional atherectomy of femoro-popliteal lesions, J Am Coll Cardiol, vol.48, 2006.

M. Werner, D. Scheinert, M. Henn, S. Scheinert, S. Bräunlich et al., Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis, Journal of Endovascular Therapy, vol.19, issue.4, pp.467-75, 2012.
DOI : 10.1583/12-3832R.1

E. Dippel, P. Makam, R. Kovach, J. George, R. Patlola et al., Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis, JACC: Cardiovascular Interventions, vol.8, issue.1
DOI : 10.1016/j.jcin.2014.09.009

M. Bosiers, K. Deloose, J. Callaert, J. Verbist, J. Hendriks et al., Superiority of Stent-Grafts for In-Stent Restenosis in the Superficial Femoral Artery, Journal of Endovascular Therapy, vol.60, issue.1, pp.1-1010, 2015.
DOI : 10.1016/j.jacc.2012.07.033

M. Werk, S. Langner, B. Reinkensmeier, H. Boettcher, G. Tepe et al., Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial, Circulation, vol.118, issue.13, pp.1358-65, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.735985

G. Tepe, J. Laird, P. Schneider, M. Brodmann, P. Krishnan et al., Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: 12-Month Results From the IN.PACT SFA Randomized Trial, Circulation, vol.131, issue.5, pp.495-502, 2015.
DOI : 10.1161/CIRCULATIONAHA.114.011004

J. Laird, P. Schneider, G. Tepe, M. Brodmann, T. Zeller et al., Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions, Journal of the American College of Cardiology, vol.66, issue.21, pp.2329-2367, 2015.
DOI : 10.1016/j.jacc.2015.09.063

K. Rosenfield, M. Jaff, C. White, K. Rocha-singh, C. Mena-hurtado et al., Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease, New England Journal of Medicine, vol.373, issue.2, pp.145-53, 2015.
DOI : 10.1056/NEJMoa1406235

H. Schroeder, M. Werner, D. Meyer, P. Reimer, K. Krüger et al., Low-Dose Paclitaxel???Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery DiseaseClinical Perspective, Circulation, vol.135, issue.23, pp.2227-2263, 2017.
DOI : 10.1161/CIRCULATIONAHA.116.026493

D. Scheinert, S. Duda, T. Zeller, H. Krankenberg, J. Ricke et al., The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization, JACC: Cardiovascular Interventions, vol.7, issue.1, pp.10-19, 2014.
DOI : 10.1016/j.jcin.2013.05.022

P. Krishnan, P. Faries, K. Niazi, A. Jain, R. Sachar et al., Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease, Circulation, vol.136, issue.12
DOI : 10.1161/CIRCULATIONAHA.117.028893

D. Scheinert, K. Schulte, T. Zeller, J. Lammer, and G. Tepe, Paclitaxel-Releasing Balloon in Femoropopliteal Lesions Using a BTHC Excipient, Journal of Endovascular Therapy, vol.5, issue.1, pp.14-21, 2015.
DOI : 10.1161/CIRCINTERVENTIONS.111.962324

X. Jia, J. Zhang, B. Zhuang, W. Fu, D. Wu et al., Acotec Drug-Coated Balloon Catheter, JACC: Cardiovascular Interventions, vol.9, issue.18, 2016.
DOI : 10.1016/j.jcin.2016.06.055

A. Micari, A. Cioppa, G. Vadalà, F. Castriota, A. Liso et al., Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease, JACC: Cardiovascular Interventions, vol.5, issue.3, 2012.
DOI : 10.1016/j.jcin.2011.11.010

A. Micari, G. Vadalà, F. Castriota, A. Liso, C. Grattoni et al., 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery??Disease, JACC: Cardiovascular Interventions, vol.9, issue.9, pp.950-956, 2016.
DOI : 10.1016/j.jcin.2016.02.014

H. Schroeder, D. Meyer, B. Lux, F. Ruecker, M. Martorana et al., Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first-in-human study, Catheterization and Cardiovascular Interventions, vol.37, issue.2, pp.278-86, 2015.
DOI : 10.1007/s00270-014-0904-3

D. Scheinert, The Lutonix EU Long Lesion study: A Prospective, Multicenter, Single-Arm Trial with the Lutonix® Drug Coated Balloon for Treatment of Long Lesions in Femoropopliteal Arteries, 2017.

L. J. In, PACT drug-coated balloon: Consistent clinical outcomes across patient populations and challenging lesions, 2017.

F. Fanelli, Optimal DCB Performance : LEVANT 2 and Global SFA Real-World Registry, 2016.

N. Zorger, C. Manke, M. Lenhart, T. Finkenzeller, B. Djavidani et al., Peripheral Arterial Balloon Angioplasty: Effect of Short versus Long Balloon Inflation Times on the Morphologic Results, Journal of Vascular and Interventional Radiology, vol.13, issue.4, pp.355-364, 2002.
DOI : 10.1016/S1051-0443(07)61736-9

H. Sakamoto, S. Nozaki, K. Misumi, M. Kurose, H. Sohara et al., Smooth Muscle Cell Proliferation in the Arterial Intima after Stretch Injury: Relationship between the Severity of Stretching and Intima Hyperplasia in New Zealand White Rabbits, Experimental Animals, vol.45, issue.1, pp.89-93, 1996.
DOI : 10.1538/expanim.45.89

D. Scheinert, A. Schmidt, T. Zeller, S. Müller-hülsbeck, S. Sixt et al., German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease, Journal of Endovascular Therapy, vol.169, issue.3, pp.409-1610, 2016.
DOI : 10.1016/j.ahj.2014.11.016

D. Scheinert, Latest Insights from the LEVANT II study and sub-group analysis, 2016.

F. Liistro, S. Grotti, I. Porto, P. Angioli, L. Ricci et al., Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery, JACC: Cardiovascular Interventions, vol.6, issue.12, pp.1295-302, 2013.
DOI : 10.1016/j.jcin.2013.07.010

G. Tepe, T. Zeller, B. Schnorr, C. Claussen, U. Beschorner et al., High-grade, non-flowlimiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study, J Endovasc Ther Off J Int Soc Endovasc Spec, vol.201, pp.792-800, 2013.

D. Ihnat, S. Duong, Z. Taylor, L. Leon, J. Mills et al., Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score, Journal of Vascular Surgery, vol.47, issue.5, pp.967-74, 2008.
DOI : 10.1016/j.jvs.2007.12.050

A. Micari, R. Nerla, G. Vadalà, F. Castriota, C. Grattoni et al., 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery??Disease, JACC: Cardiovascular Interventions, vol.10, issue.7, pp.728-762, 2017.
DOI : 10.1016/j.jcin.2017.01.028

P. Schneider, DCB and restenosis: who fails and why? What we do about it now and what the future holds, 2017.

A. Schmidt, M. Piorkowski, H. Görner, S. Steiner, Y. Bausback et al., Drug-Coated Balloons for Complex Femoropopliteal Lesions, JACC: Cardiovascular Interventions, vol.9, issue.7, pp.715-739, 2016.
DOI : 10.1016/j.jcin.2015.12.267

M. Herten, G. Torsello, E. Schönefeld, B. Imm, N. Osada et al., Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis, Journal of Vascular Surgery, vol.61, issue.2, pp.394-403, 2015.
DOI : 10.1016/j.jvs.2014.08.005

S. Sixt, C. Cancino, O. Treszl, A. Beschorner, U. Macharzina et al., Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries, Journal of Vascular Surgery, vol.58, issue.3, pp.682-688, 2013.
DOI : 10.1016/j.jvs.2013.02.019

R. Gandini, D. Giudice, C. Merolla, S. Morosetti, D. Pampana et al., Treatment of Chronic SFA In-Stent Occlusion With Combined Laser Atherectomy and Drug-Eluting Balloon Angioplasty in Patients With Critical Limb Ischemia: A Single-Center, Prospective, Randomized Study, Journal of Endovascular Therapy, vol.20, issue.6, pp.805-819, 2013.
DOI : 10.1583/13-4308MR.1

F. Fanelli, A. Cannavale, M. Gazzetti, P. Lucatelli, A. Wlderk et al., Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial Disease, CardioVascular and Interventional Radiology, vol.37, issue.5, pp.898-907, 2014.
DOI : 10.1016/S0735-1097(01)01175-5

J. Laird, Current status of drug coated balloon treatment in the SFA: What do the 3 year outcomes from the IN.PACT SFA RCT tell us, 2017.

H. Jongsma, J. Bekken, J. De-vries, H. Verhagen, and B. Fioole, Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease, Journal of Vascular Surgery, vol.64, issue.5, pp.1503-1517, 2016.
DOI : 10.1016/j.jvs.2016.05.084

A. Micari, A. Cioppa, G. Vadalà, F. Castriota, A. Liso et al., 2-Year Results of Paclitaxel-Eluting Balloons for Femoropopliteal Artery Disease, JACC: Cardiovascular Interventions, vol.6, issue.3, pp.282-291, 2013.
DOI : 10.1016/j.jcin.2013.01.128

M. Thieme, V. Bilderling, P. Paetzel, C. Karnabatidis, D. et al., The 24-Month Results of the Lutonix??Global SFA Registry, JACC: Cardiovascular Interventions, vol.10, issue.16, 2017.
DOI : 10.1016/j.jcin.2017.04.041

H. Jongsma, J. Bekken, J. De-vries, H. Verhagen, and B. Fioole, Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease, Journal of Vascular Surgery, vol.64, issue.5, pp.1503-1517, 2016.
DOI : 10.1016/j.jvs.2016.05.084

N. Candy, E. Ng, and R. Velu, Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty, Journal of Vascular Surgery, vol.65, issue.2, pp.558-570, 2017.
DOI : 10.1016/j.jvs.2016.10.089

D. Giacoppo, S. Cassese, Y. Harada, R. Colleran, J. Michel et al., Drug-Coated Balloon Versus Plain Balloon??Angioplasty for the Treatment of??Femoropopliteal Artery Disease, JACC: Cardiovascular Interventions, vol.9, issue.16, pp.1731-1773, 2016.
DOI : 10.1016/j.jcin.2016.06.008

S. Cassese, R. Byrne, I. Ott, G. Ndrepepa, M. Nerad et al., Paclitaxel-Coated Versus Uncoated Balloon Angioplasty Reduces Target Lesion Revascularization in Patients With Femoropopliteal Arterial Disease: A Meta-Analysis of Randomized Trials, Circulation: Cardiovascular Interventions, vol.5, issue.4, pp.582-591, 2012.
DOI : 10.1161/CIRCINTERVENTIONS.112.969972

G. Tepe, B. Schnorr, T. Albrecht, K. Brechtel, C. Claussen et al., Angioplasty of femoralpopliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial, JACC Cardiovasc Interv, vol.8, 2015.

W. Guo, 2-year results of the AcoArt I - RCT for the Use of the Orchid ® DCB in Femoral popliteal Artery Disease, 2017.

F. Kolodgie, E. Pacheco, K. Yahagi, H. Mori, E. Ladich et al., Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine, Journal of Vascular and Interventional Radiology, vol.27, issue.11, 2016.
DOI : 10.1016/j.jvir.2016.06.036

A. Finn, A study of downstream events of the two leading DCBs on the market, 2017.

K. Katsanos, S. Spiliopoulos, N. Karunanithy, M. Krokidis, T. Sabharwal et al., Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery, Journal of Vascular Surgery, vol.59, issue.4, 2014.
DOI : 10.1016/j.jvs.2014.01.041

M. Lichtenberg, Role of vessel preparation in contemporary DCB practice, 2017.

K. Rosenfield, M. Jaff, C. White, K. Rocha-singh, C. Mena-hurtado et al., Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease, New England Journal of Medicine, vol.373, issue.2, pp.145-53, 2015.
DOI : 10.1056/NEJMoa1406235

D. Scheinert, 6-month Results of the RANGER SFA Randomized Study of the Ranger Paclitaxel- Coated Balloon: Diabetic Subgroup, 2017.

T. Albrecht, Final angiographic and clinical 12-month results of the CONSEQUENT trial, 2017.

D. Scheinert, 2-year result of the REAL PTX - randomized clinical trial comparing Zilver PTX vs. DCB treatment in femoropoliteal lesions, 2017.

T. Foley, R. Cotter, D. Kokkinidis, D. Nguyen, S. Waldo et al., Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease, Catheterization and Cardiovascular Interventions, vol.45, issue.6, pp.1078-85, 2017.
DOI : 10.1016/j.jacc.2004.11.026

U. Beschorner, Repetetive DCB treatment for femoropopliteal lesions ? a viable solution for recurrent lesions? LINC, 2017.

J. Pietzsch, B. Geisler, A. Garner, T. Zeller, and M. Jaff, Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany, Catheterization and Cardiovascular Interventions, vol.61, issue.4, pp.546-54, 2014.
DOI : 10.1016/j.jacc.2013.03.034

M. Herten, G. Torsello, E. Schönefeld, and S. Stahlhoff, Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease, Vascular Health and Risk Management, vol.12, pp.341-56, 2016.
DOI : 10.2147/VHRM.S81122

A. Salisbury, H. Li, K. Vilain, M. Jaff, P. Schneider et al., Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons??Versus Standard Percutaneous Transluminal Angioplasty, JACC: Cardiovascular Interventions, vol.9, issue.22, pp.2343-52, 2016.
DOI : 10.1016/j.jcin.2016.08.036

B. Cortese, J. Granada, B. Scheller, P. Schneider, G. Tepe et al., Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document, European Heart Journal, vol.37, issue.14, pp.1096-103, 2016.
DOI : 10.1093/eurheartj/ehv204

V. Aboyans, J. Ricco, M. Bartelink, M. Björck, M. Brodmann et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS), European Heart Journal
DOI : 10.1093/eurheartj/ehx095

F. Fanelli, Treatment strategies for SFA disease. LINC 2016

D. Au-moment, être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité. Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

. Je-respecterai-toutes-les, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité